Other antianginal drugs
Drug Safety Update
January 2016: Nicorandil should be reserved for patients with stable angina inadequately controlled by first line drugs or where first line agents are contraindicated/not tolerated. Nicorandil can cause serious skin, mucosal and eye ulceration which persists unless treatment is stopped.
December 2014: Ivabradine is associated with a risk of bradycardia, atrial fibrillation and other cardiac side effects. Check contraindications and cautions for prescribing.
NICE Guidance (see drug-specific links below)
| Pack | Price |
|---|---|
| 60 tablet | £1.74 |
| Pack | Price |
|---|---|
| 60 tablet | £2.17 |
| Pack | Price |
|---|---|
| 56 tablet | £28.71 |
| Pack | Price |
|---|---|
| 56 tablet | £5.36 |
Used as add-on therapy for patients with stable angina who are inadequately controlled. Interacts with a wide range of medication and patients must carry an alert card. Ongoing prescribing & monitoring should remain with the specialist.
| Pack | Price |
|---|---|
| 60 tablet | £48.98 |
| Pack | Price |
|---|---|
| 60 tablet | £48.98 |
| Pack | Price |
|---|---|
| 60 tablet | £48.98 |